Epithelial-mesenchymal transition and its implications for fibrosis

Journal of Clinical Investigation

Volumn 112, Issue 12, 2003, Pages 1776-1784

  Kalluri, Raghu ^a   Neilson, Eric G ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; BETA INTEGRIN; CALVASCULIN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; CYTOKERATIN 18; CYTOKINE; DESMOPLAKIN; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR 8; FIBRONECTIN; GELATINASE A; GELATINASE B; GROWTH FACTOR; GUANOSINE TRIPHOSPHATASE; MITOGEN ACTIVATED PROTEIN KINASE; OSTEOGENIC PROTEIN 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN; SMAD3 PROTEIN; SOMATOMEDIN B; SYNDECAN 1; THROMBOSPONDIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN;

ANIMAL CELL; ANIMAL MODEL; CELL DIFFERENTIATION; CELL MIGRATION; ENZYME ACTIVATION; EPITHELIUM CELL; EXTRACELLULAR MATRIX; FIBROBLAST; FIBROSIS; GLOMERULONEPHRITIS; KIDNEY FIBROSIS; MESENCHYME CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ANIMALS; CYTOKINES; EPITHELIUM; FIBROBLASTS; FIBROSIS; GROWTH SUBSTANCES; HUMANS; KIDNEY; KIDNEY DISEASES; MESODERM; MODELS, BIOLOGICAL; PROTEOME;

EID: 0346724511     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200320530     Document Type: Review

References (154)

1. Virchow, R. 1858. Die Cellularpathologie in ihrer Begründung auf physiologische und pathologische Gewebelehre. A. Hirschwald, Berlin, Germany. 456 pp.
2. Slack, J.M.W. 2000. Stem cells in epithelial tissues. Science. 287:1431-1433.
3. Watt, F.M., and Hogan, B.L. 2000. Out of Eden: stem cells and their niches. Science. 287:1427-1430.
4. Blau, H.M., Brazelton, T.R., and Weimainn, J.M. 2001. The evolving concept of a stem cell: entity or function? Cell. 105:829-841.
5. Irvine, K.D., and Rauskolb, C. 2001. Boundaries in development: formation and Function. Annu. Rev. Cell Dev. Biol. 17:189-214.
6. Sengel, P. 1990. Pattern Formation in skin development. Int. J. Dev. Biol. 34:33-50
7. Erickson, C.A., and Reedy, M.V. 1998. Neural crest development: the interplay between morphogenesis and cell differentiation. Curr. Top. Dev. Biol. 40:177-209.
8. Hogan, B.L., and Kolodziej, P.A. 2002. Organogenesis: molecular mechanisms of tubulogenesis. Nat. Rev. Genet. 3:513-523.
9. Krasnow, M.A., and Nelson, W.J. 2002. Tube morphogenesis. Trends Cell Biol. 12:351.
10. Lubarsky, B., and Krasnow, M.A. 2003. Tube morphogenesis: making and shaping biological tubes. Cell. 112:19-28.
11. Gumbiner, B.M. 1992. Epithelial morphogenesis. Cell. 69:385-387.
12. Yeaman, C., Grindstaff, K.K., Hansen, M.D., and Nelson, W.J. 1999. Cell polarity: versatile scaffolds keep things in place. Curr. Biol. 9:R515-517.
13. Al-Awqati, Q., Vijayakumar, S., and Takito, J. 2003. Terminal differentiation of epithelia. Biol. Chem. 384:1255-1258.
14. Boyer, B., Valles, A.M., and Edme, N. 2000. Induction and regulation of epithelial-mesenchymal transitions. Biochem. Pharmacol. 60:1091-1099.
15. Nieto, M.A. 2002. The snail superfamily of zinc-finger transcription factors Nat. Rev. Mol. Cell Biol. 3:155-166.
16. Tsai, R. Y., Kittappa, R., and McKay, R.D. 2002. Plasticity, niches, and the use of stem cells. Dev. Cell. 2:707-712.
17. Hay, E.D. 1995. An overview of epithelio-mesenchymal transformations. Acta Anat. 154:8-20.
18. Strutz, F., et al. 1995. Identification and characterization of a Fibroblast marker: FSPI. J. Cell Biol. 130:393-405.
19. Iwano, M., et al. 2002. Evidence that Fibroblasts derive from epithelium during tissue fibrosis. J. Clin. Invest. 110:341-350.doi:10.1172/JC1200215518.
20. Kiemer, A.K., Takeuchi, K., and Quinlan, M.P. 2001. Identification of genes involved in epithelial-mesenchymal transition and tumor progression. Oncogene. 20:6679-6688.
21. Janda, E., et al. 2002. Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways. J. Cell Biol. 156:299-313.
22. Vincent-Salomon, A., and Thiery, J.P. 2003. Host microenvironment in breast cancer development: epithelial-mesenchymal transition in breast cancer development. Breast Cancer Res. 5:101-106.
23. Xue, C., Plieth, D., Venkov, C., Xu, C., and Neilson, E.G. 2003. The gate-keeper effect of epithelial-mesenchymal transition regulates the frequency of breast cancer metastases. Cancer Res. 63:3386-3394.
24. Slack, J.M., and Tosh, D. 2001. Transdifferentiation and metaplasia-switching cell types. Curr. Opin. Genet. Dev. 11:581-586.
25. Eguchi, G., and Kodama, R. 1993. Transdifferentiation. Curr. Opin. Cell Biol. 5:1023-1028,
26. Ric-Tsonis, K.D., and Tsonis, P.A. 2003. Eye regeneration at the molecular age. Dev. Dyn. 226:211-224.
27. Cinti, S. 2002. Adipocyte differentiation and transdifferentiation: plasticity of the adipose organ. J. Endocrinol. Invest. 25:823-835.
28. Frid, M.G., Kale, VA., and Stenmark, K.R. 2002. Mature vascular endothelium can give rise to smooth muscle cells via endothelial-mesenchymal transdifferentiation: in vitro analysis. Circ. Res. 90:1189-1196.
29. Vidal, S., Horvath, E., Kovacs, K., Lloyd, R.V., and Smyth, H.S. 2001. Reversible transdifferentiation: interconversion of somatotrophs and lacrotrophs in pituitary hyperplasia. Mod. Pathol. 14:20-28.
30. Rooman, I., Heremans, Y., Heimberg, H., and Bouwens, L. 2000. Modulation of rat pancreatic acinoductal transdifferentiation and expression of PDX-1 in vitro. Diabetologia. 43:907-914.
31. Hall, P.A., and Lemoine, N.R. 1992. Rapid acinar to ductal transdifferentiation in cultured human exocrine pancreas. J. Pathol. 166:97-103.
32. Shen, C.N., Slack, J. M., and Tosh, D. 2000. Molecular basis of transdifferentiation of pancreas to liver. Nat. Cell Biol. 2:879-887.
33. Shen, C.N., Horb, M.E., Slack, J.M., and Tosh, D. 2003. Transdifferentiation of pancreas to liver. Mech. Dev. 120:107-116.
34. Horb, M.E., Shen, C.N., Tosh, D., and Slack, J.M. 2003. Experimental conversion of liver to pancreas. Curr. Biol. 13:105-115.
35. Tam, P.P., and Behringer, R.R. 1997. Mouse gastrulation: the formation of a mammalian body plan. Mech. Dev. 68:3-25.
36. Narasimha, M., and Leptin, M. 2000. Cell movements during gastrulation: come in and be induced. Trends Cell Biol. 10:169-172.
37. Carver, E.A., Jiang, R., Lan, Y., Oram, K.F., and Gridley, T. 2001. The mouse snail gene encodes a key regulator of the epithelial-mesenchymal transition. Mol. Cell Biol. 21:8184-8188.
38. Summerbell, D., and Rigby, P.W. 2000. Transcriptional regulation during somitogenesis. Curr. Top. Dev. Biol. 48:301-318.
39. Pourquie, O. 2001. Vertebrate somitogenesis. Annu. Rev. Cell Dev. Biol. 17:311-350.
40. Ekblom, P. 1989. Developmentally regulated conversion of mesenchyme to epithelium. FASEB J. 3:2141-2150.
41. Birchmeier, W., and Birchmeier, C. 1994. Mesenchymal-epithelial transitions. Bioessays. 16:305-307.
42. Barasch, J., et al. 1999. Mesenchymal to epithelial conversion in rat metanephros is induced by LIF. Cell. 99:377-386.
43. Desmouliere, A. 1995. Factors influencing myofibroblast differentiation during wound healing and fibrosis. Cell Biol. Int. 19:471-476.
44. Lochter, A. 1998. Plasticity of mammary epithelia during normal development and neoplastic progression. Biochem. Cell Biol. 76:997-1008.
45. Guarino, M., Micheli, P., Pallotti, F., and Giordano, F. 1999. Pathological relevance of epithelial and mesenchymal phenotype plasticity. Pathol. Res. Pract. 195:379-389.
46. Yang, J., and Liu, Y. 2001. Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial Fibrosis. Am. J. Pathol. 159:1465-1475.
47. Zeisberg, M., Maeshima, Y., Mosterman, B., and Kalluri, R. 2002. Renal fibrosis. Extracellular matrix microenvironment regulates migratory behavior of activated tubular epithelia] cells. Am. J. Pathol. 160:2001-2008.
48. Zeisberg, M., et al. 2001. Renal fibrosis: collagen composition and assembly regulates epithelial-mesenchymal transdifferentiation. Am. J. Pathol. 159:1313-1321.
49. Fan, J.M., et al. 1999. Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro. Kidney Int. 56:1455-1467.
50. Okada, H., Danoff, T.M., Kalluri, R., and Neilson, E.G. 1997. The early role of FSP1 in epithelial-mesenchymal transformation. Am. J. Physiol. 273:563-574.
51. Morali, O.G., et al. 2001. IGF-II induces rapid beta-catenin relocation to the nucleus during epithelium to mesenchyme transition. Oncogene. 20:4942-4950.
52. Scrutz, F., et al. 2002. Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation. Kidney Int. 61:1714-1728.
53. Bhowmick, N. A., Zent, R., Ghiassi, M., McDonnell, M., and Moses, H.L. 2001. Integrin beta 1 signaling is necessary for transforming growth factor-beta activation of p38MAPK and epithelial plasticity. J. Biol. Chem. 276:46707-46713.
54. Zeisberg, M., et al. 2003. BMP-7 counteracts TGF-beta 1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Mat. Med. 9:964-968.
55. Boyer, A.S., Erickson, C.P., and Runyan, R.B. 1999. Epithelial-mesenchymal transformation in the embryonic heart is mediated through distinct pertussis toxin-sensitive and TGFβ signal transduction mechanisms. Dev. Dyn. 214:81-91,
56. Yu, L., Hebert, M.C., and Zhang, Y.E. 2002. TGF-beta receptor-activated p38 MAP kinase mediates Smad-independent TGF-beta responses. EMBO J. 21:3749-3759.
57. Boyer, A.S., et al. 1999. TGFbeta2 and TGFbeta3 have separate and sequential activities during epithelial-mesenchymal cell transformation in the embryonic heart. Dev. Biol. 208:530-545.
58. Bhowmick, N.A., et al. 2001. Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol. Biol. Cell. 12:27-36.
59. Camenisch, T.D., et al. 2002. Temporal and distinct TGFbeta ligand requirements during mouse and avian endocardial cushion morphogenesis. Dev. Biol. 248:170-181.
60. Miettinen, P.J., Ebner, R., Lopez, A.R., and Derynck, R. 1994. TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J. Cell Biol. 127:2021-2036.
61. Derynck, R., and Zhang, Y.E. 2003. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature. 425:577-584.
62. Citterio, H.L., and Gaillard, D.A. 1994. Expression of transforming growth factor alpha (TGF alpha), epidermal growth factor receptor (EGF-R) and cell proliferation during human palatogenesis: an immunohistochemical study. Int. J. Dev. Biol. 38:499-505.
63. Morabito, C.J., Dettman, R.W., Katran, J., Collier, J.M., and Bristow J. 2001. Positive and negative regulation of epicardial-mesenchymal transformation during avian heart development. Dev. Biol 234:204-215.
64. Thery, C., and Stern, C.D. 1996. Roles of kringle domain-containing serine proteases in epithelial-mesenchymal transitions during embryonic development. Acta Anat. (Basel). 156:162-172.
65. Lamorte, L., Royal, I., Naujokas, M., and Park, M. 2002. Crk adapter proteins promote an epithelial-mesenchymal-like transition and are required for HGF-mediated cell spreading and breakdown of epithelial adherens junctions. Mol. Biol. Cell. 13:1449-1461.
66. Song, W., Majka, S.M., and McGuire, P.G. 1999. Hepatocyte growth factor expression in the developing myocardium: evidence for a role in the regulation of the mesenchymal cell phenotype and urokinase expression. Dev. Dyn. 214:92-100.
67. Thery, C., Sharpe, M.J., Batley, SJ., Stern, C.D., and Gherardi, E. 1995. Expression of HGF/SF, HGF1/MSP, and c-met suggests new functions during early chick development. Dev. Genet. 17:90-101.
68. Nusrat, A., et al. 1994. Hepacocyte growth factor/scatter factor effects on epithelia. Regulation of intercellular junctions in transformed and nontransformed cell lines, basolateral polarization of c-met receptor in transformed and natural intestinal epithelia, and induction of rapid wound repair in a transformed model epithelium. J. Clin. Invest. 93:2056-2065.
69. Mizuno, S., et al. 1998. Hepatocyte growth factor prevents renal fibrosis and dysfunction in a mouse model of chronic renal disease. J. Clin. Invest. 101:1827-1834.
70. Etienne-Manneville, S., and Hall, A. 2002. Rho GTPases in cell biology. Nature. 420:629-635,
71. Bar-Sagi, D., and Hall, A. 2000. Ras and Rho GTPases: a family reunion. Cell. 103:227-238.
72. Savagner, P. 2001. Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition. Bioessays. 23:912-923.
73. Kim, K., Lu, Z., and Hay, E.D. 2002. Direct evidence for a role of beta-catenin/LEF-1 signaling pathway in induction of EMT. Cell Biol. Int. 26:463-476.
74. Hall, A. 1998. Rho GTPases and the actin cytoskeleton. Science. 279:509-514.
75. Li, Y., Yang, J, Dai, C., Wu, C., and Liu, Y. 2003. Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis. J. Clin. Invest. 112:503-516. doi:10.1172/JC1200317913.
76. Novak, A., et al. 1998. Cell adhesion and the integrin-linked kinase regulate the LEF-1 and beta-catenin signaling pathways. Proc. Natl. Acad. Sci. U. S. A. 95:4374-4379.
77. Espada, J., Perez-Moreno, M., Braga, V.M., Rodriguez-Viciana, R. and Cano, A. 1999. H-Ras activation promotes cytoplasmic accumulation and phosphoinositide 3-OH kinase association of beta-catenin in epidermal keratinocytes. J. Cell Biol. 146:967-980.
78. Behrens, J., et al. 1993. Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/beta-catenin complex in cells transformed with a temperature-sensitive v-SRC gene. J. Cell Biol. 120:757-766.
79. Smith, D.E., Franco del Amo, F., and Gridley, T. 1992. Isolation of Sna, a mouse gene homologous to the Drosophila genes snail and escargot: its expression pattern suggests multiple roles during postimplantation development. Development. 116:1033-1039.
80. Attisano, L., and Wrana, J.L. 2002. Signal transduction by the TGF-beta superfamily. Science. 296:1646-1647.
81. He, X. 2003. A wnt-wnt situation. Dev. Cell. 4:791-797.
82. Sadot, E., Geiger, B., Oren, M., and Ben-Ze'ev, A. 2001. Down-regulation of beta-catenin by activated p53. Mol. Cell. Biol. 21:6768-6781.
83. Aberle, H., Bauer, A., Stappert, J., Kispert, A., and Kemler, R. 1997. beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J. 16:3797-3804.
84. von Kries, J.P., et al. 2000. Hot spots in beta-catenin for interactions with LEF-1, conductin and APC. Nat. Struct. Biol. 7:800-807,
85. Kim, K., and Hay, E.D. 2001. New evidence that nuclear import of endogenous beta-catenin is LEF-1 dependent, while LEF-1 independent import of exogenous beta-catenin leads to nuclear abnormalities. Cell Biol. Int. 25:1149-1161.
86. Midgley, C.A., et al. 1997. APC expression in normal human tissues. J. Pathol. 181:426-433.
87. Ip, Y.T., and Gridley, T. 2002, Cell movements during gastrulation: snail dependent and independent pathways. Curr. Opin. Genet. Dev. 12:423-429.
88. Zavadil, J., et al. 2001. Genetic programs of epithelial cell plasticity directed by transforming growth factor-beta. Proc. Natl. Acad. Sci. U. S. A. 98:6686-6691.
89. Ramaswamy, S., Ross, K.N., Lander, E.S., and Golub, T.R. 2003. A molecular signature of metastasis in primary solid tumors. Nat. Genet. 33:49-54.
90. Blau, H.M., and Blakely, B.T. 1999. Plasticity of cell fate: insights from heterokaryons. Semin. Cell Dev. Biol. 10:267-272.
91. Emerson, B.M. 2002. Specificity of gene regulation. Cell. 109:267-270.
92. Cremer, T., and Cremer, C. 2001. Chromosome territories, nuclear architecture and gene regulation in mammalian cells. Nat. Rev. Genet. 2:292-301.
93. Mannervik, M., Nibu, Y., Zhang, H., and Levine, M. 1999. Transcriptional coregulators in development. Science. 284:606-609,
94. Young, B.A., Gruber, T.M., and Gross, C.A. 2002. Views of transcription initiation. Cell. 109:417-420.
95. Peinado, H., Quintanilla, M., and Cano, A. 2003. Transforming growth factor beta 1 induces snail transcription factor in epithelial cell lines. Mechanisms for epithelial-mesenchymal transitions. J. Biol. Chem. 278:21113-21123.
96. Lie-Venerna, H., et al. 2003. Ets-1 and Ets-2 transcription factors are essential for normal coronary and myocardial development in chicken embryos. Circ. Res. 92:749-756.
97. Macias, D., Perez-Pomares, J.M., Garcia-Garrido, L., Carmona, R., and Munoz-Chapuli, R. 1998. Immunoreactivity of the ets-1 transcription factor correlates with areas of epithelial-mesenchymal transition in the developing avian heart. Anat. Embryol. (Berl.), 198:307-315.
98. Ridinger, K., et al. 1998. Clustered organization of S100 genes in human and mouse. Biochim. Biopbys. Acta. 1448:254-263.
99. Iwano, M., et al. 2001. Conditional abatement of tissue fibrosis using nucleoside analogs to selectively corrupt DNA replication in transgenic fibroblasts. Mol. Ther. 3:149-15b.
100. Barraclough, R. 1998. Calcium-binding protein S100A4 in health and disease. Biochim. Biophys. Acta. 1448:190-199.
101. Grigorian, M., et al. 2001. Tumor suppressor p53 protein is a new target for the metastasis-associated Mts1/S100A4 protein: functional consequences of their interaction. J. Biol. Chem. 276:22699-22708.
102. Chen H., et al. 2001. Binding to intracellular targets of the metastasis-inducing protein, S100A4 (p9Ka). Biochem. Biophys. Res. Commun. 286:1212-1217.
103. Ambartsumian, N., et al. 2001. The metastasis-associated Mts1(S100A4) protein could act as an angiogenic factor. Oncogene. 20:4685-4695.
104. Okada, H., et al. 1998. Novel cis-acting elements in the FSP1 gene regulate Fibroblast-specific transcription. Am. J. Physiol. 275:306-314.
105. Tian, Y.C., Fraser, D., Attisano, L., and Phillips, A.O. 2003. TGF-{beta}1-mediated alterations of renal proximal tubular epithelial cell phenotype. Am. J. Physiol. Renal Physiol. 285:F130-F142.
106. Thiery, J.P., and Chopin, D. 1999. Epithelial cell plasticity in development and tumor progression. Cancer Metastasis Rev. 18:31-42.
107. Quilliam, L.A., Rebhun, J.F., and Castro, A.F. 2002. A growing family of guanine nucleotide exchange factors is responsible for activation of Ras-family GTPases. Prog. Nucleic Acid Res. Mol. Biol. 71:391-444.
108. Bernards, A. 2003. GAPs galore! A survey of putative Ras superfamily GTPase activating proteins in man and Drosophila. Biochim. Biophys. Acta. 1603:47-82.
109. Masszi, A., et al. 2003. Central role for Rho in TGF-beta1-induced alpha-smooth muscle actin expression during epithelial-mesenchymal transition. Am. J. Physiol. Renal Physiol. 284:F911-924.
110. Ridley, A.J., Paterson, H.F., Johnston, C.L., Diekmann, D., and Hall, A. 1992. The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell. 70:401-410.
111. Nobes, C.D., and Hall, A. 1995. Rho, rac and cdc42 GTPases: regulators of actin structures, cell adhesion and motility. Biochem. Soc. Trans. 23:456-459.
112. Sander, E.E., ten Klooster, J.P., van Delft, S., van der Kammen, R.A., and Collard, J.G. 1999. Rac downregulates Rho activity: reciprocal balance between both GTPases determines cellular morphology and migratory behavior. J. Cell Biol. 147:1009-1022.
113. Zondag, G.C., et al. 2000. Oncogenic Ras downregulates Rac activity, which leads to increased Rho activity and epithelial-mesenchymal transition. J. Cell Biol. 149:775-782.
114. Cohnheim, J. 1867. Übet Entzündung und Eiterung. Virchows Arch. 40:1-79.
115. Abe, R., Donnelly, S.C., Peng, T., Bucala, R., and Metz, C.N. 2001. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J. Immunol. 166:7556-7562.
116. Huss, R. 2000. Isolation of primary and immortalized CD34-hematopoietic and mesenchymal stem cells from various sources. Stem Cells. 18:1-9.
117. Bianco, P., and Robey, P.G. 2000. Marrow stromal cells. J. Clin. Invest, 105:1663-1668.
118. Bi, L.X., Simmons, D.J., Hawkins, H.K., Cox, R.A., and Mainous, E.G. 2000. Comparative morphology of the marrow sac. Anat. Rec. 260:410-415.
119. Simmons, D.J. 1996. The in vivo role of bone marrow Fibroblast-like stromal cells. Calcif. Tissue Int. 58:129-132.
120. Weiss, L., and Geduldig, U. 1991. Barrier cells: stromal regulation of hematopoiesis and blood cell release in normal and stressed murine bone marrow. Blood. 78:975-990.
121. Zhang, J., et al. 2003. Identification of the haematopoietic stem cell niche and control of the niche size. Nature. 425:836-841.
122. Krause, D.S., et al. 2001. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell. 105:369-377
123. Huss, R., Hong, D.S., McSweeney, P.A., Hoy, C.A., and Deeg, HJ. 1995. Differentiation of canine bone marrow cells with hemopoietic characteristics from an adherent stromal cell precursor. Proc. Natl. Acad. Sci U. S. A. 92:748-752.
124. Huss, R. 2000. Perspectives on the morphology and biology of CD34-negative stem cells. J. Hematother. Stem Cell Res. 9:783-793.
125. Garrett, D.M., and Conrad, G.W. 1979. Fibroblast-like cells from embryonic chick cornea, heart, and skin are antigenically distinct. Dev. Biol. 70:50-70.
126. Schor, S.L., and Schor, A.M. 1987. Clonal heterogeneity in fibroblast phenotype: implications for the control of epithelial-mesenchymal interactions. Bioessays. 7:200-204.
127. Müller, G.A., and Rodemann, H.P. 1991. Characterization of human renal fibroblasts in health and disease. I. Immunophenotyping of cultured tubular epithelial cells and fibroblasts derived from kidneys with histologically proven interstitial fibrosis. Am. J. Kidney Dis. 17:680-683.
128. Dugina, V., Alexandrova, A., Chaponnier, C., Vasiliev, J., and Gabbiani, G. 1998. Rat fibroblasts cultured from various organs exhibit differences in alpha-smooth muscle actin expression, cytoskeletal pattern, and adhesive structure organization. Exp. Cell. Res. 238:481-490.
129. Alvarez, R.J., et al. 1992. Biosynthetic and proliferative characteristics of tubulointerstitial fibroblasts probed with paracrine cytokines. Kidney Int. 41:14-23.
130. Chang, H.Y., et al. 2002. Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc. Natl. Acad. Sci. U. S. A. 99:12877-12882.
131. Chilosi, M., et al. 2003. Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis. Am. J. Pathol. 162:1495-1502.
132. Kalluri, R., Danoff, T.M., Okada, H., and Neilson, E.G. 1997. Susceptibility to anti-glomerular basement membrane disease and Goodpasture syndrome is linked to MHC class II genes and the emergence of T cell-mediated immunity in mice. J. Clin. Invest. 100:2263-2275.
133. Cosgrove, D., et al. 1996. Collagen COL4A3 knockout: a mouse model for autosomal Alport syndrome. Genes Dev. 10:2981-2992.
134. Anders, H., and Schlondorff, D. 2000. Murine models of renal disease: possibilities and problems in studies using mutant mice. Exp. Nephrol. 8:181-193.
135. Janssen, U., Phillips, A.O., and Floege, J. 1999. Rodent models of nephropathy associated with type II diabetes. J. Nephrol. 12:159-172.
136. Diamond, J.R., Ricardo, S.D., and Klahr, S. 1998. Mechanisms of interstitial fibrosis in obstructive nephropathy. Semin. Nephrol. 18:594-602.
137. Okada, H., et al. 2000. Progressive renal fibrosis in murine polycystic kidney disease: an immunohistochemical observation. Kidney Int. 58:587-597.
138. Okada, H., Strutz, F., Danoff, T.M., Kalluri, R., and Neilson, E.G. 1996. Possible mechanisms of renal fibrosis. Contrib. Nephrol. 118:147-154.
139. Breen, E., Falco, V.M., Absher, M., and Cutroneo, K.R. 1990. Subpopulations of rat lung fibroblasts with different amounts of type I and type III collagen mRNAs. J. Biol. Chem. 265:6286-6290.
140. Goldring, S.R., Stephenson, M.L., Downie, E., Krane, S.M., and Korn, J.H, 1990. Heterogeneity in hormone responses and patterns of collagen synthesis in cloned dermal fibroblasts. J. Clin. Invest. 85:798-803.
141. Jelaska, A., Strehlow, D., and Korn, J.H. 1999. Fibroblast heterogeneity in physiological conditions and fibrotic disease. Springer Semin. Immunopathol. 21:385-395.
142. Rossert, R.A., Chen, S.S., Eberspaecher, H., Smith, C.N., and De Crombrugghe, B. 1996. Identification of a minimal sequence of the mouse pro-a1(I) collagen promoter that confers high-level osteoblast expression in transgenic mice and that binds a protein selectively present in osteoblasts. Proc. Natl. Acad. Set. U. S. A. 93:1027-1031.
143. Zeisberg, M., Strutz, F., and Muller, G.A. 2000. Role of Fibroblast activation in inducing interstitial fibrosis. J. Nephrol. 13(Suppl. 3):S111-S120.
144. Serini, G., and Gabbiani, G. 1999. Mechanisms of myofibroblast activity and phenotypic modulation. Exp. Cell Res. 250:273-283.
145. Tang, W.W., et al. 1996. Platelet-derived growth Factor-BB induces renal tubulointerstitial myofibroblast formation and tubulointerstitial fibrosis. Am. J. Pathol. 148:1169-1180.
146. Ng, Y.Y., et al. 1998. Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats. Kidney Int. 54:864-876.
147. Eyden, B. 2001. The myofibroblast: an assessment of controversial issues and a definition useful in diagnosis and research. Ultrastruct. Pathol. 25:39-50.
148. Yang, J., et al. 2002. Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy. J. Clin. Invest. 110:1525-1538. doi:10.1172/JC1200216219.
149. Yang, J., and Liu, Y. 2002. Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis. J. Am. Sec. Nephrol. 13:96-107.
150. Zeisberg, M., et al. 2003. Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two generic mouse models. Am. J. Physiol. Renal Physiol. 285:F1060-F1067.
151. Kalluri, R., and Zeisberg, M. 2003. Exploring the connection between chronic renal fibrosis and bone morphogenic protein-7. Histol. Histopathol. 18:217-224.
152. Morrissey, J., et al. 2002. Bone morphogenetic protein-7 improves renal fibrosis and accelerates the return of renal function. J. Am. Soc. Nephrol. 13(Suppl. 1):S14-S21.
153. Wang, S., et al. 2003. Bone morphogenic protein-7 (BMP-7), a novel therapy for diabetic nephropathy. Kidney Int. 63:2037-2049.
154. Gould, S.J., and Vrba, E.S. 1982. Exaptation - a missing term in the science of form. Paleobiology. 8:4-15.